1. Academic Validation
  2. CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons

CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons

  • Ann N Y Acad Sci. 1994 Mar 23;713:300-11. doi: 10.1111/j.1749-6632.1994.tb44078.x.
K Rasmussen 1
Affiliations

Affiliation

  • 1 Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285.
Figures
Products